Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacy Loeb

Showing results (121-130 of 499) with videos related to

Pageof 50
Sort By:
Nature Reviews. Urology|September 23, 2015
Prostate cancer: Growth of AS in the USA signals reduction in overtreatmentDeclan G Murphy, Stacy Loeb
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff valuesWilliam J Catalona, Stacy Loeb
Reviews in Urology|November 18, 2009
Randomized trials of prostate cancer screeningStacy Loeb, Alan W Partin
Current Opinion in Urology|June 30, 2017
Genomic testing for localized prostate cancer: where do we go from here?Stacy Loeb, Ashley E Ross
European Urology|August 5, 2015
Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and MelanomaStacy Loeb, Thorsten Schlomm, Pär Stattin
European Urology|March 18, 2014
Social media offers unprecedented opportunities for vibrant exchange of professional ideas across continentsStacy Loeb, James Catto, Alexander Kutikov
Urology Practice|August 18, 2023
Editorial CommentaryShannon Ciprut, Caitlin Curnyn, Stacy Loeb
The Journal of Urology|June 4, 2013
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancerStacy Loeb, Anders Berglund, Pär Stattin
Reviews in Urology|March 25, 2014
Updates in the care and management of prostate cancer: highlights from the 2013 prostate cancer world congress, august 6-10, 2013, melbourne, australiaMarnique Basto, Aine Goggins, Stacy Loeb
The Journal of Urology|January 20, 2016
Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma: D. F. Penson J Urol 2015;194:1710-1711Stacy Loeb, Mats Lambe, Pär Stattin
Pageof 50

Showing results (121-130 of 499) with videos related to

Sort By:
Pageof 50
Nature Reviews. Urology|September 23, 2015
Prostate cancer: Growth of AS in the USA signals reduction in overtreatmentDeclan G Murphy, Stacy Loeb
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff valuesWilliam J Catalona, Stacy Loeb
Reviews in Urology|November 18, 2009
Randomized trials of prostate cancer screeningStacy Loeb, Alan W Partin
Current Opinion in Urology|June 30, 2017
Genomic testing for localized prostate cancer: where do we go from here?Stacy Loeb, Ashley E Ross
European Urology|August 5, 2015
Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and MelanomaStacy Loeb, Thorsten Schlomm, Pär Stattin
European Urology|March 18, 2014
Social media offers unprecedented opportunities for vibrant exchange of professional ideas across continentsStacy Loeb, James Catto, Alexander Kutikov
Urology Practice|August 18, 2023
Editorial CommentaryShannon Ciprut, Caitlin Curnyn, Stacy Loeb
The Journal of Urology|June 4, 2013
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancerStacy Loeb, Anders Berglund, Pär Stattin
Reviews in Urology|March 25, 2014
Updates in the care and management of prostate cancer: highlights from the 2013 prostate cancer world congress, august 6-10, 2013, melbourne, australiaMarnique Basto, Aine Goggins, Stacy Loeb
The Journal of Urology|January 20, 2016
Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma: D. F. Penson J Urol 2015;194:1710-1711Stacy Loeb, Mats Lambe, Pär Stattin
Pageof 50